Cardlytics Reports Director/Officer Changes
Ticker: CDLX · Form: 8-K · Filed: Dec 5, 2025 · CIK: 1666071
| Field | Detail |
|---|---|
| Company | Cardlytics, Inc. (CDLX) |
| Form Type | 8-K |
| Filed Date | Dec 5, 2025 |
| Risk Level | medium |
| Pages | 2 |
| Reading Time | 2 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: leadership-change, officer-appointment, director-election
Related Tickers: CDLX
TL;DR
Cardlytics is shuffling its execs and board members, effective Dec 3rd.
AI Summary
Cardlytics, Inc. filed an 8-K on December 5, 2025, reporting changes effective December 3, 2025. The filing pertains to the departure of directors or certain officers, the election of directors, the appointment of certain officers, and compensatory arrangements for certain officers. Specific details regarding the individuals involved, their roles, and the nature of the compensatory arrangements are not provided in this excerpt.
Why It Matters
Changes in a company's board of directors and executive officers can signal shifts in strategy, governance, or operational focus.
Risk Assessment
Risk Level: medium — Changes in key leadership and compensatory arrangements can indicate internal shifts that may impact future performance.
Key Players & Entities
- Cardlytics, Inc. (company) — Registrant
- December 3, 2025 (date) — Effective date of reported events
- December 5, 2025 (date) — Filing date of the 8-K
FAQ
What specific changes were made regarding directors or officers?
The filing indicates the departure of directors or certain officers, the election of directors, and the appointment of certain officers, but the specific names and roles are not detailed in this excerpt.
What is the effective date of these reported changes?
The earliest event reported is dated December 3, 2025.
What is the filing date of this Form 8-K?
The Form 8-K was filed on December 5, 2025.
What are the main topics covered in this 8-K filing?
This filing covers the departure of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements of certain officers.
Where is Cardlytics, Inc. headquartered?
Cardlytics, Inc. is headquartered at 675 Ponce de Leon Avenue NE, Suite 4100, Atlanta, Georgia 30308.
Filing Stats: 541 words · 2 min read · ~2 pages · Grade level 13 · Accepted 2025-12-05 08:04:20
Filing Documents
- cdlx-20251203.htm (8-K) — 27KB
- cdlx-20251203_g1.jpg (GRAPHIC) — 26KB
- 0001666071-25-000166.txt ( ) — 230KB
- cdlx-20251203.xsd (EX-101.SCH) — 3KB
- cdlx-20251203_def.xml (EX-101.DEF) — 14KB
- cdlx-20251203_lab.xml (EX-101.LAB) — 25KB
- cdlx-20251203_pre.xml (EX-101.PRE) — 15KB
- cdlx-20251203_htm.xml (XML) — 3KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized. Cardlytics, Inc. Date: December 5, 2025 By: /s/ Amit Gupta Amit Gupta Chief Executive Officer (Principal Executive Officer)